R.PR
REGISTERED-PRINCIPAL REGISTER
12/21/2021
Back to search
Official data from USPTO
CP CITRAGEN PHARMACEUTICALS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/21/2021
Trademark type
Combined
Nice classes
5
Filing date
01/22/2021
Registration date
12/21/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/21/2021
Last transaction
12/21/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
03/01/2018
First use in commerce
03/01/2018
Drawing code
3
Owner type
03
Owner location
Fremont, CA, US
Examiner
OAKES, JEFFREY ALLEN
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of intertwined stylized letters "C" and "P" inside a box, all to the left of the stylized wording "CITRAGEN" above the stylized wording "PHARMACEUTICALS, INC".
Holders and representatives
Holders
CitraGen Pharmaceuticals, Inc.
Representatives
Christina S. Loza LOZA & LOZA, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention or treatment of painfevercoldsgastrointestinal disorderscardiovascular diseaseshemorrhoidsskin rasheseczemahormonal imbalancesfungal infectionsitchingeye diseases and disordersnasal care and disordersrespiratory diseases and disordersear disordersmultiple sclerosishemophiliaurologic diseasescancerosteoporosisclimacteric diseaseselectrolyte disorders and balancebone diseases and disordersblood related disordersmenstrual symptomsskin diseases and disordersmental disorders; dietary supplements; medical foods in the nature of dietetic foods adapted for medical purposes; pharmaceutical preparations being acid reducers; anti-acids being antacids; allergy relief medications; analgesics; antacids; antihistamines; pharmaceutical antitussive cold preparations; pharmaceutical anti-diarrheal preparations; cough syrups; expectorants; decongestant capsules and tablets; decongestant nasal spray; laxatives; medicinal gastrointestinal preparations; sleeping tablets; medicated smoking cessation gums and lozenges
Publications
History of USPTO decisions and trademark events.
27 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/05/2021
PUBO
PUBLISHED FOR OPPOSITION
10/05/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/15/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
08/27/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/27/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
08/27/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/27/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/23/2021
GNRT
NON-FINAL ACTION E-MAILED
08/23/2021
CNRT
NON-FINAL ACTION WRITTEN
08/23/2021
DOCK
ASSIGNED TO EXAMINER
08/05/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/24/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/24/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/24/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/24/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/24/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/27/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/27/2021
NWAP
NEW APPLICATION ENTERED
01/26/2021
Continuous trademark protection
Get notified about every new filing that threatens CP CITRAGEN PHARMACEUTICALS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.